Investor Relations
Croma is a global player and challenger in the dynamically growing, minimally invasive aesthetics market, a family business with more than 40 years of experience and a leading manufacturer of premium-quality HA syringes.
We offer our customers, health care professionals, a comprehensive, innovative portfolio of safe, reliable, efficacious products from one trusted source and have been striving for innovation since our foundation, focusing on in-house R&D and high standards in the clinical development of our products.
Investor Presentation
Find here the link to the current Croma Company Presentation for investors
Financial Statements 2022
Please find here Croma’s Financial Statements 2022
Press Releases
Please find here Croma's latest press release on the financial statements 2022. For more information, please visit the press page.